Literature DB >> 23936549

A 40-year-old woman with locally advanced rectal cancer and a solitary liver metastasis.

Carla Hajj1, Karyn Goodman, David Kelsen, Jinru Shia, Ali Shamseddine, Mohamed Naghy, Mustafa Sidani, Mohamed Eloubeidi, Fady Merhi, Fady Geara, Celina Ang, Leonard Saltz, Ghassan K Abou-Alfa.   

Abstract

Entities:  

Year:  2013        PMID: 23936549      PMCID: PMC3737511     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


× No keyword cloud information.
  16 in total

Review 1.  AGA technical review on hereditary colorectal cancer and genetic testing.

Authors:  F M Giardiello; J D Brensinger; G M Petersen
Journal:  Gastroenterology       Date:  2001-07       Impact factor: 22.682

2.  Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer.

Authors:  P Peltomäki; H F Vasen
Journal:  Gastroenterology       Date:  1997-10       Impact factor: 22.682

3.  Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study.

Authors:  C Bokemeyer; I Bondarenko; J T Hartmann; F de Braud; G Schuch; A Zubel; I Celik; M Schlichting; P Koralewski
Journal:  Ann Oncol       Date:  2011-01-12       Impact factor: 32.976

4.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

Review 5.  Imaging of transposed ovaries in patients with cervical carcinoma.

Authors:  Tamar Sella; Svetlana Mironov; Hedvig Hricak
Journal:  AJR Am J Roentgenol       Date:  2005-05       Impact factor: 3.959

6.  Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest.

Authors:  Alfredo Falcone; Sergio Ricci; Isa Brunetti; Elisabetta Pfanner; Giacomo Allegrini; Cecilia Barbara; Lucio Crinò; Giovanni Benedetti; Walter Evangelista; Laura Fanchini; Enrico Cortesi; Vincenzo Picone; Stefano Vitello; Silvana Chiara; Cristina Granetto; Gianfranco Porcile; Luisa Fioretto; Cinzia Orlandini; Michele Andreuccetti; Gianluca Masi
Journal:  J Clin Oncol       Date:  2007-05-01       Impact factor: 44.544

7.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Authors:  Asad Umar; C Richard Boland; Jonathan P Terdiman; Sapna Syngal; Albert de la Chapelle; Josef Rüschoff; Richard Fishel; Noralane M Lindor; Lawrence J Burgart; Richard Hamelin; Stanley R Hamilton; Robert A Hiatt; Jeremy Jass; Annika Lindblom; Henry T Lynch; Païvi Peltomaki; Scott D Ramsey; Miguel A Rodriguez-Bigas; Hans F A Vasen; Ernest T Hawk; J Carl Barrett; Andrew N Freedman; Sudhir Srivastava
Journal:  J Natl Cancer Inst       Date:  2004-02-18       Impact factor: 13.506

8.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

Review 9.  The role of preoperative chemotherapy in patients with resectable colorectal liver metastases.

Authors:  Stéphane Benoist; Bernard Nordlinger
Journal:  Ann Surg Oncol       Date:  2009-06-25       Impact factor: 5.344

Review 10.  Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients.

Authors:  Jennifer Y Wo; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-04-01       Impact factor: 7.038

View more
  1 in total

1.  A 39-year-old female patient with metastatic rectal cancer develops thrombocytopenia.

Authors:  Haifaa Dbouk; Simon Mentha; Deborah Mukherji; Jean Lee; Ali Haydar; Ali Shamseddine; Eileen M O'Reilly; Leonard Saltz; Ghassan K Abou-Alfa
Journal:  Gastrointest Cancer Res       Date:  2014-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.